CrushSCI.com
Journal Selection & Manuscript Polishing Services
INTERNATIONAL JOURNAL OF CANCER journal cover Medicine
Back to journal directory

Review Cycle Records

INTERNATIONAL JOURNAL OF CANCER

Wiley SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
142.1Average days
147Median days
10Fastest days
440Longest days
5442025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

157 days

Trends in Incidence Rates of Anogenital Cancers in Costa Rica, 1996–2022

AuthorsLoretto J. Carvajal; Jaimie Z. Shing; Juan Carlos Vanegas; Rebeca Ocampo; Emmanuel González; Diego Guillén; Carolina Porras; Rolando Herrero; Alejandro Calderón; Meredith S. Shiels; Rachel Slimovitch; Mónica S. Sierra; Joel M. Palefsky; Cameron Haas; Danping Liu; Aimée R. Kreimer; Romain Fantin

Affiliations1. Agencia Costarricense de Investigaciones Biomédicas (ACIB), Fundación INCIENSA (FUNIN) San José Costa Rica; 2. Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health Rockville Maryland USA; 3. Patología quirúrgica Hospital Clínica Bíblica San José Costa Rica; 4. Área de Investigación en Salud y Seguridad Social, Caja Costarricense de Seguro Social San José Costa Rica; 5. Department of Epidemiology Boston University School of Public Health Boston Massachusetts USA; 6. Division of Infectious Diseases, Department of Medicine University of California, San Francisco San Francisco California USA

Source PDF DOI Publisher page
17 days

Comments on “Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma”

AuthorsChen‐Guang Liu; Junyuan Yang; Ruijun Luo; Rui Sun; Min Peng

Affiliations1. Cancer Center Renmin Hospital of Wuhan University Wuhan China

Source PDF DOI Publisher page
127 days

Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer

AuthorsShinkichi Takamori; Tateaki Naito; Nobuko Konishi; Tetsuya Tsuji; Ikumi Takashima; Ryotaro Ide; Masakazu Fujiwara; Atsuki Yamamoto; Yusuke Takagi; Mizue Ogi; Shinya Uematsu; Hiroshi Kitagawa; Koichi Takayama

Affiliations1. Department of Surgery and Science Graduate School of Medical Sciences, Kyushu University Fukuoka Japan; 2. Department of Medical Oncology Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA; 3. Division of Thoracic Oncology Shizuoka Cancer Center Shizuoka Japan; 4. Department of Rehabilitation National Cancer Center Hospital East Kashiwa Chiba Japan; 5. Department of Rehabilitation Medicine Keio University School of Medicine Tokyo Japan; 6. Medical Department AstraZeneca K.K. Osaka Japan; 7. Department of Pulmonary Medicine Graduate School of Medical Science, Kyoto Prefectural University of Medicine Kyoto Japan

Source PDF DOI Publisher page
154 days

Comparative Effectiveness of Induction Chemotherapy Regimens in Pediatric and Adolescent Locally Advanced Nasopharyngeal Carcinoma: A Retrospective IPTW Analysis

AuthorsRui‐Ling Xie; Ye‐Hao Zou; Zi‐Xuan Chen; Ling‐Ling Zhang; Chao Lin; Rui Sun

Affiliations1. Department of Nasopharyngeal Carcinoma Sun Yat‐Sen University Cancer Center Guangzhou China; 2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Sun Yat‐Sen University Cancer Center Guangzhou China; 3. Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐Sen University Cancer Center Guangzhou China; 4. Department of Radiation Oncology FuJian Medical University Union Hospital Fuzhou Fujian China

Source PDF DOI Publisher page
180 days

Incidence and Predictors of Immune‐Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real‐World Cohort Study

AuthorsFreya Koffka; Johann Kornowski; Elena Laakmann; Barbara Schmalfeldt; Tim Zell; Glenn Geidel; Christoffer Gebhardt; Pia Roser; Volkmar Müller; Julian Kött

Affiliations1. Department of Gynecology University Medical Center Hamburg‐Eppendorf Hamburg Germany; 2. Department of Dermatology and Venereology University Medical Center Hamburg‐Eppendorf Hamburg Germany; 3. Fleur Hiege Center for Skin Cancer Research University Medical Center Hamburg‐Eppendorf Hamburg Germany; 4. Department of Endocrinology and Diabetology University Medical Center Hamburg‐Eppendorf Hamburg Germany

Source PDF DOI Publisher page
166 days

Sex‐Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement‐Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma

AuthorsAlexander Quaas; Hanna Schiemann; Su Ir Lyu; Thomas Zander; Axel Hillmer; Hans Schlößer; Christiane J. Bruns; Reinhard Büttner; Bastian Grothey

Affiliations1. Institute of Pathology, Faculty of Medicine and University Hospital of Cologne, University of Cologne Cologne Germany; 2. Department of Internal Medicine I University Hospital Cologne, Medical Faculty, University of Cologne Cologne Germany; 3. Department of General, Visceral and Cancer Surgery, Faculty of Medicine University Hospital of Cologne Cologne Germany

Source PDF DOI Publisher page
170 days

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting

AuthorsFederica Lo Prinzi; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung‐Yeh; Stephen Lam Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii‐Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Arndt Vogel; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei‐Gardini

Affiliations1. Fondazione Policlinico Universitario Campus Bio‐Medico Roma Italy; 2. IRCCS San Raffaele Hospital Milan Italy; 3. Vita‐Salute San Raffaele University Milan Italy; 4. Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Kashiwa Japan; 5. Department of Internal Medicine Mayo Clinic Phoenix USA; 6. Clinical Oncology Unit Careggi University Hospital Florence Italy; 7. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 8. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital Seoul National University College of Medicine Seongnam‐si Gyeonggi‐do Republic of Korea; 9. Oncology 1 Unit, Department of Medical Oncology Veneto Institute of Oncology IOV – IRCCS Padua Italy; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology Hannover Medical School Hannover Germany; 11. Humanitas Cancer Center IRCCS Humanitas Research Hospital Milan Rozzano Italy; 12. Unit of Medical Oncology 2 Azienda Ospedaliero‐Universitaria Pisana Pisa Italy; 13. Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy; 14. Department of Medical Oncology IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori” Meldola Italy; 15. Digestive Oncology University Hospitals Leuven Leuven Belgium; 16. University of Glasgow (School of Cancer Sciences), Beatson West of Scotland Centre CRUK Scotland Centre Glasgow UK; 17. Department of Surgery & Cancer Imperial College London, Hammersmith Hospital London UK; 18. Department of Oncology and Palliative Care Cardinale G. Panico, Tricase City Hospital Tricase Italy; 19. Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy; 20. Santa Maria Delle Croci Hospital, AUSL Romagna Ravenna Italy; 21. Department of DIMEC University of Bologna Ravenna Italy; 22. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron University Hospital Barcelona Spain; 23. UOC Oncologia A, Department of Hematology, Oncology and Dermatology, Policlinico Umberto I Sapienza University of Rome Rome Italy; 24. Clinica Oncologica e Centro Regionale di Genetica Oncologica Università Politecnica Delle Marche, Azienda Ospedaliero‐Universitaria Delle Marche Ancona Italy; 25. Digestive Unit, Champalimaud Clinical Centre Champalimaud Research Centre Lisbon Portugal; 26. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center CHA University School of Medicine Seongnam Republic of Korea; 27. Department of Medical Oncology, OncoHealth Institute Fundacion Jimenez Diaz University Hospital Madrid Spain; 28. Department of Medical Oncology, Onco‐Health Research Institute Fundacion Jimenez Diaz University Hospital (IIS‐FJD) Madrid Spain; 29. Universidad Autonoma de Madrid (UAM) Madrid Spain; 30. Medical Oncology and Biomedical Therapy Policlinico Riuniti Foggia Italy; 31. Medical Clinic 1, University Hospital Goethe‐University Frankfurt Frankfurt am Main Germany; 32. Dipartimento di Oncologia Medica Fondazione Poliambulanza Brescia Italy; 33. Clinical Experimental Abdominal Oncology Unit Istituto Nazionale Tumori‐IRCCS Fondazione G. Pascale Naples Italy; 34. IRCCS Istituto Nazionale Tumori Regina Elena Roma Italy; 35. Internal Medicine 1 University Hospital Ulm Ulm Germany; 36. Germany Institute of Molecular Oncology and Stem Cell Biology Ulm University Hospital Ulm Germany; 37. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital Inje University College of Medicine Busan Republic of Korea; 38. Oncologia Medica, Dipartimento di Medicina dei Sistemi Università di Tor Vergata Roma Italy; 39. Department of Medical Oncology Unidade Local de Saude do Algarve (ULSAlg) Faro Portugal; 40. Medical Oncology Unit University Hospital of Parma Parma Italy; 41. Medical Oncology Unit, Department of Internal Medicine IRCCS Policlinico San Matteo Pavia Italy; 42. Medical Oncology Candiolo Cancer Institute FPO‐IRCCS Candiolo Italy; 43. Oncology Department University of Turin Turin Italy; 44. Medical Oncology IRCCS Ospedale Policlinico San Martino Genova Italy; 45. Oncology Unit Ospedale del Mare Napoli Italy; 46. ASAN Medical Center University of Ulsan College of Medicine Seoul Republic of Korea; 47. Medical Oncology Unit, Department of Oncology and Hematology Belcolle Hospital Viterbo Italy; 48. Oncology Unit Fondazione IRCCS Casa Sollievo Della Sofferenza San Giovanni Rotondo Italy; 49. Medical Oncology University and University Hospital of Cagliari Cagliari Italy; 50. GI Oncology Unit and Familial Cancer Unit, Oncology Department Hospital Universitario 12 de Octubre Madrid Spain; 51. Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milan Italy; 52. Department of Medicine I, Clinical Division of Oncology Medical University Vienna Wien Austria; 53. Department of Medical Oncology AULSS 8 Berica Vicenza Italy; 54. UOC Oncologia Territoriale, Polo Pontino La Sapienza Università Di Roma Latina Italy; 55. National Institute of Cancer Research National Health Research Institutes Tainan Taiwan; 56. Department of Oncology, National Cheng Kung University Hospital, College of Medicine National Cheng Kung University Tainan Taiwan; 57. State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer Prince of Wales Hospital, the Chinese University of Hong Kong Hong Kong Hong Kong; 58. Department of Biomedical Sciences Humanitas University Milan Pieve Emanuele Italy; 59. Long Family Chair in Liver Cancer Research, Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre Schwartz Reisman Liver Research Centre Toronto Canada

Source PDF DOI Publisher page
140 days

Fruit and Vegetable Intake in Relation to the Risks of Lung, Colorectal, Stomach, and Overall Cancers in China: A Prospective Cohort Study

AuthorsJun Li; Xin Yin; Genming Zhao; Xing Liu; Minqi Wei; Jiayue Chen; Yonggen Jiang; Qian Peng; Jianhua Shi; Weixi Li; Na Wang

Affiliations1. Minhang District Center for Disease Control and Prevention (Minhang District Institute of Health Supervision) Shanghai China; 2. School of Public Health, Fudan University Shanghai China; 3. Songjiang District Center for Disease Control and Prevention (Songjiang District Institute of Health Supervision) Shanghai China; 4. Jiading District Center for Disease Control and Prevention (Jiading District Institute of Health Supervision) Shanghai China; 5. Xuhui District Center for Disease Control and Prevention (Xuhui District Institute of Health Supervision) Shanghai China

Source PDF DOI Publisher page
157 days

Risk of Developing Subsequent Primary Colorectal Cancers Among Non‐Colorectal Cancer Survivors: Implications for Prevention and Screening

AuthorsDylan E. O'Sullivan; Robert J. Hilsden; Hannah Harsanyi; Matthew T. Warkentin; Kareem Jamani; Huiming Yang; Darren R. Brenner; Safiya Karim; Winson Y. Cheung; Yibing Ruan

Affiliations1. Department of Cancer Epidemiology and Prevention Research Cancer Care Alberta, Arthur Child Cancer Centre Calgary Alberta Canada; 2. Department of Oncology University of Calgary Calgary Alberta Canada; 3. Department of Community Health Sciences University of Calgary Calgary Alberta Canada; 4. Forzani & MacPhail Colon Cancer Screening Centre, Alberta Health Services Calgary Alberta Canada; 5. Department of Medicine Cumming School of Medicine Calgary Alberta Canada; 6. Division of Hematology, Department of Medicine, Cumming School of Medicine University of Calgary Calgary Alberta Canada; 7. Screening Programs, Provincial Population and Public Health Alberta Health Services Calgary Alberta Canada

Source PDF DOI Publisher page
22 days

Comments on “Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition ( EPIC ) Study”

AuthorsMan Sun; Dan Zang; Jun Chen

Affiliations1. Department of Oncology The Second Hospital of Dalian Medical University Dalian City Liaoning Province China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.